GLP-1 medications get at the heart of addiction: study Dr. Kamal Kant Kohli10 March 2026 9:00 PM ISTResearchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and...
Adding Fourth Oral Drug Beats Metformin Dose Escalation in Uncontrolled Type 2 Diabetes: EFFORT Trial Medha Baranwal10 March 2026 9:00 AM ISTSouth Korea: A new multicenter clinical trial published in Diabetes, Obesity & Metabolism suggests that intensifying treatment with a fourth oral...
Medical Bulletin 09/March/2026 Anshika Mishra9 March 2026 3:00 PM ISTHere are the top medical news for today:Scientists Explain Why We Still Crave Food After Feeling Full The global obesity epidemic has become a major...
Seven Hours of Sleep Linked to Lower Insulin Resistance Risk: Study Shows Anshika Mishra9 March 2026 8:30 AM ISTA large observational study suggests that sleeping about 7 hours and 18 minutes per night may be the optimal duration for reducing the risk of insulin...
Pfizer's GLP-1 Drug Xianweiying Wins China Approval for Long-Term Weight Management sheeba farhat8 March 2026 11:30 AM ISTShanghai: China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said...
Beyond Glycaemia- Weight Reduction Is the New Additional Therapeutic Endpoint in T2D Dr. Kamal Kant Kohli7 March 2026 10:59 AM ISTIndia bears a disproportionate share of the global diabetes burden, with 89.8 million adults living with T2DM against a worldwide estimate of 589...
GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death: Study Dr. Kamal Kant Kohli5 March 2026 9:30 AM ISTGlucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of...
GLP-1 Drugs Linked to Modest Rise in Fracture Risk in Older Adults with Type 2 Diabetes: Study Medha Baranwal4 March 2026 8:45 AM ISTIsrael: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely used for their glycemic and cardiovascular benefits in type 2 diabetes, may be...
Medical Bulletin 03/March/2026 Anshika Mishra3 March 2026 3:00 PM ISTHere are the top medical news for today:New Study Raises Health Concerns Over Popular Bubble Tea Bubble tea’s colorful presentation and chewy tapioca...
Oral Semaglutide Cuts Heart Failure Events in Diabetes Patients With Prior HF: SOUL Trial Analysis Medha Baranwal3 March 2026 9:45 AM ISTUSA: Oral semaglutide may lower the risk of heart failure-related events in people with type 2 diabetes who already have heart failure, without...
New Study Raises Health Concerns Over Popular Bubble Tea Anshika Mishra3 March 2026 8:00 AM ISTBubble tea's colorful presentation and chewy tapioca pearls have made it a global sensation since its origins in 1980s Taiwan. Now widely available...
NICE 2026 Updates Type 2 Diabetes Care: Cardiovascular Focus, Early SGLT-2 Use Takes Forefront Aditi Dhingra2 March 2026 12:30 PM ISTThe most recent version of NG28, the National Institute for Health and Care Excellence's (NICE) guidelines for managing type 2 diabetes in adults, has...
